Table 1 of
Xu, Mol Vis 2016; 22:275-283.
Table 1. Summary analysis of rhythmicity for retinal and Müller cell preparations.
Preparation | Period (h) | Power | Goodness (%) | N |
---|---|---|---|---|
Per2::Luc MMC | 24.05±0.11 | 0.170±0.121 | 27.616±12.00 | 6 |
MMC with Per2::Luc lentivirus | 22.67±2.11 | 0.163±0.114 | 15.07±4.53 | 4 |
MMC with Bmal1::Luc lentivirus | 23.98±0.12 | 0.147±0.105 | 23.86±9.22 | 7 |
Per1::Luc Retina | 24.1±3.89 | 0.197±0.20 | 20.42±13.64 | 6 |
Per1−/−/Per2::Luc Retina | ns | 0.010±0.008 | 8.98±5.60 | 3 |
Per1−/−/Per2::Luc MMC | ns | 0.032±0.018 | 20.57±4.47 | 3 |
Bmal1−/− Per2::Luc Retina | ns | 0.0087±0.0089 | 17.87±6.27 | 3 |
Bmal1−/− Per2::Luc MMC | ns | 0.051±0.039 | 8.31±1.96 | 3 |
Per1::Luc MMC | ns | 0.00034±0.000016 | 15.45±0.99 | 4 |
Per2::Luc MMC with control siRNA | 23.99±0.12 | 0.193±0.171 | 25.85±22.78 | 4 |
Per2::Luc MMC with lipofectamine | 23.96 | 0.26 | 29.8 | 1 |
Per2::Luc MMC with Per1 siRNA | ns | 0.032±0.007 | 9.19±1.06 | 2 |
Per2::Luc MMC with Per2 siRNA | ns | 0.0172±0.018 | 4.055±3.31 | 2 |
Per2::Luc MMC with Bmal1 siRNA | ns | 0.006±0.004 | 0.02±0.66 | 4 |
HMC with Per2::Luc lentivirus | 23.32±1.51 | 0.474±0.076 | 54.2±9.37 | 5 |
HMC with Per2::Luc lentivirus control siRNA | 22.87±1.95 | 0.45±0.072 | 55.8±9.47 | 3 |
HMC with Per2::Luc lentivirus lipofectamine | 22.37±2.48 | 0.43±0.014 | 52.65±13.93 | 2 |
HMC with Per2::Luc lentivirus Per1 siRNA | 22.87±1.96 | 0.16±0.107 | 20.99±10.97 | 3 |
HMC with Per2::Luc lentivirus Per2 siRNA | 24.03±0.099 | 0.396±0.104 | 42.68±9.53 | 5 |
HMC with Per2::Luc lentivirus Bmal1 siRNA | ns | 0.035±0.050 | 12.5±2.36 | 3 |